Regional Gene Therapy Consultant for DEB Launch

Krystal Biotech, Inc.; Seattle (WA); On-site; USD 185,000 - 215,000; Full time

Job summary

Krystal Biotech, Inc. is seeking a Regional Gene Therapy Consultant (RGTC) to lead the launch of Vyjuvek for dystrophic epidermolysis bullosa (DEB) in their territory.

The role emphasizes patient-centric sales, accountability, and collaboration with internal teams to ensure patient access and education. TheRGTC will drive a comprehensive territory plan, build strong relationships with dermatology specialists and key stakeholders, and represent the voice of the customer in Krystal’s commercial

Qualifications

• 7+ years of pharmaceutical sales experience, with dermatology and rare disease background.
• Product launch experience required; start-up experience is desired.
• Experience operating in complex reimbursement environments.

Responsibilities

• Achieve/exceed sales goals in the assigned territory promoting Vyjuvek to pediatric dermatologists and other stakeholders.
• Develop territory strategies and account plans; assess opportunities for successful launch.
• Promote and educate HCPs on Vyjuvek, its indications, safety and efficacy, and optimize access at the site of care.

Skills

Pharmaceutical sales

Dermatology sales

Rare disease sales

Product launch

Cross-functional collaboration

Communication skills

Education

BS/BA degree

Tools

CRM software

Job description

Krystal Biotech, Inc. is seeking a Regional Gene Therapy Consultant (RGTC) to lead the launch of Vyjuvek for dystrophic epidermolysis bullosa (DEB) in their territory.

The role emphasizes patient-centric sales, accountability, and collaboration with internal teams to ensure patient access and education. TheRGTC will drive a comprehensive territory plan, build strong relationships with dermatology specialists and key stakeholders, and represent the voice of the customer in Krystal’s commercial